Highly Loaded Erlotinib Tubular Micromotor for Targeted Drug Delivery, pH Responsive Release and Ultrasound Tracking: A Three-In-One Micromachine.
2/5 보강
TL;DR
A novel erlotinib ‐loaded calcium carbonate (CaCO3) tubular micromotor fabricated via an internal‐filling strategy, achieving a high drug payload of 2.53 × 10−12 mol per micromotor, which integrates three core functionalities in one system: targeted delivery of EH, pH‐responsive release, and ultrasound‐based tracking.
OpenAlex 토픽 ·
Micro and Nano Robotics
Nanoparticle-Based Drug Delivery
Supramolecular Chemistry and Complexes
A novel erlotinib ‐loaded calcium carbonate (CaCO3) tubular micromotor fabricated via an internal‐filling strategy, achieving a high drug payload of 2.53 × 10−12 mol per micromotor, which integrates t
APA
Xiaochun Li, Kaiying Liang, et al. (2026). Highly Loaded Erlotinib Tubular Micromotor for Targeted Drug Delivery, pH Responsive Release and Ultrasound Tracking: A Three-In-One Micromachine.. Small methods, 10(7), e01926. https://doi.org/10.1002/smtd.202501926
MLA
Xiaochun Li, et al.. "Highly Loaded Erlotinib Tubular Micromotor for Targeted Drug Delivery, pH Responsive Release and Ultrasound Tracking: A Three-In-One Micromachine.." Small methods, vol. 10, no. 7, 2026, pp. e01926.
PMID
41622551 ↗
Abstract 한글 요약
Herein, we report a novel erlotinib (EH) -loaded calcium carbonate (CaCO) tubular micromotor fabricated via an internal-filling strategy, achieving a high drug payload of 2.53 × 10 mol per micromotor, which integrates three core functionalities in one system: targeted delivery of EH, pH-responsive release, and ultrasound-based tracking. The microtube structures (10 µm in diameter) are prepared by electrochemical deposition, followed by filling the EH@CaCO microparticle into the interior of the tubular motor. Distinct from the surface coating approach for drug immobilization, this internal-filling strategy enables substantially greater payloads. The EH@CaCO tubular micromotor shows favorable bubble and magnetic propulsion capabilities. Serving as a proof-of-concept for targeted anti-cancer drug delivery, these micromotors can transport drugs within microchips channel to the targeted position. Under acidic conditions, CaCO undergoes decomposition to release the encapsulated drug. Concurrently, the Zn-based inner structure of the tubular micromotor reacts with hydrogen ions (H), leading to micromotor degradation and thereby facilitating rapid drug release. The as-released drug shows cell killing ability toward non-small cell lung cancer cells A549. Meanwhile, as the micromotors move in an acidic environment, the in situ generated bubbles can act as "ultrasonic contrast agents", thereby enabling real-time tracking of the micromotors. For potential in vivo applications, this facilitates the tracking of such motors in scenarios where optical microscopy is ineffective. The blood compatibility, coagulation function, and preliminary in vivo immune response evaluation all indicate that the system had good biosafety. This study provides a new idea for the development of a next-generation micro drug delivery platform with high drug loading, intelligent delivery, and real-time visualization.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Progress of clinical research on fractional laser treatment of androgenetic alopecia: A review article.
- Efficacy and Safety of Botulinum Toxin Type A for Treatment of Glabellar Lines: A Network Meta-Analysis of Randomized Controlled Trials.
- Sunken Upper Eyelid Deformity Correction by Orbital Fat Pad Repositioning and Orbicularis Oculi Muscle Folding in Blepharoplasty.
- Forehead Fat Grafting: Asian Facial Contouring and Augmentation.
- Effects of Virtual Reality-Based Cognitive Behavioral Therapy on Sick Role Adaptation for Patients With Colorectal Cancer: A Randomised Controlled Trial.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.